Haemonetics reports Q1 FY2027 results; no financial details in filing

HAEMONETICS CORP

2027-Q1 EPS reported $0.72 revenue$339,380,000

Press release issued on August 6, 2026 for quarter ended June 27, 2026.
Exhibit 99.1 referenced but not appended; specific results unavailable.
No guidance, segment data, or material changes disclosed in the 8-K body.

item 2.02 item 9.01

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-26-000118

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.